Pharmaceutical Management

USAID supports the development of new drug treatment regimens and new drugs that are easier to use, safer, lower in cost, and less labor intensive to administer. Current projects include research on fixed-dose combinations of TB drugs, intermittent and shorter treatment regimens, and the use of newly approved antibiotics. These products have the potential to improve DOTS programs through decreased operational costs, lower overall health expenditures and improved patient adherence, leading to higher cure rates and fewer cases of drug resistance. Clinical trials to assess the efficacy of proposed regimens are also supported.

Drug Management Cycle: Policy and Legal Framework

The Drug Management Cycle explains the framework for drug management support for TB.